Comprehensive Rimonabant Evaluation Study of Cardiovascular ENDpoints and Outcomes
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
43 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Sanofi-Aventis Administrative Office
Buenos Aires, Argentina
- Sanofi-Aventis Australia & New Zealand Administrative Office
Macquarie Park, New South Wales, Australia
- Sanofi-Aventis Administrative Office
Vienna, Austria
- Sanofi-Aventis Administrative Office
Diegem, Belgium
- Sanofi-Aventis Administrative Office
São Paulo, Brazil
- Sanofi-Aventis Administrative Office
Laval, Quebec, Canada
- Sanofi-Aventis Administrative Office
Santiago, Chile
- Sanofi-Aventis Administrative Office
Shangaï, China
- Sanofi-Aventis Administrative Office
Bogotá, Colombia
- Sanofi-Aventis Administrative Office
Prague, Czechia
- Sanofi-Aventis Administrative Office
Hørsholm, Denmark
- Sanofi-Aventis Administrative Office
Helsinki, Finland
- Sanofi-Aventis Administrative Office
Paris, France
- Sanofi-Aventis Administrative Office
Berlin, Germany
- Sanofi-Aventis Administrative Office
Athens, Greece
- Sanofi-Aventis Administrative Office
Hong Kong, Hong Kong
- Sanofi-Aventis Administrative Office
Budapest, Hungary
- Sanofi-Aventis Administrative Office
Mumbai, India
- Sanofi-Aventis Administrative Office
Dublin, Ireland
- Sanofi-Aventis Administrative Office
Netanya, Israel
- Sanofi-Aventis Administrative Office
Milan, Italy
- Sanofi-Aventis Administrative Office
Kuala Lumpur, Malaysia
- Sanofi-Aventis Administrative Office
México, Mexico
- Sanofi-Aventis Administrative Office
Gouda, Netherlands
- Sanofi-Aventis Administrative Office
Lysaker, Norway
- Sanofi-Aventis Administrative Office
Lima, Peru
- Sanofi-Aventis Administrative Office
Makati City, Philippines
- Sanofi-Aventis Administrative Office
Warsaw, Poland
- Sanofi-Aventis Administrative Office
Porto Salvo, Portugal
- Sanofi-Aventis Administrative Office
Bucharest, Romania
- Sanofi-Aventis Administrative Office
Moscow, Russia
- Sanofi-Aventis Administrative Office
Singapore, Singapore
- Sanofi-Aventis Administrative Office
Midrand, South Africa
- Sanofi-Aventis Administrative Office
Seoul, South Korea
- Sanofi-Aventis Administrative Office
Madrid, Spain
- Sanofi-Aventis Administrative Office
Bromma, Sweden
- Sanofi-Aventis Administrative Office
Geneva, Switzerland
- Sanofi-Aventis Administrative Office
Taipei, Taiwan
- Sanofi-Aventis Administrative Office
Bangkok, Thailand
- Sanofi-Aventis Administrative Office
Mégrine, Tunisia
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Dec 2005
- Primary completion
- 30 Apr 2009
- Completion
- 30 Apr 2009
- Last update posted
- 20 May 2016
- Registered enrollment
- 18,695
- Registry id
- NCT00263042
Cross-registrations
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.